Indications
- Prostate Cancer (see Prostate Cancer, [[Prostate Cancer]])
Pharmacology
- xxx
Administration
- PO:
Adverse Effects
Pulmonary Adverse Effects
- Interstitial Pneumonitis (see Interstitial Lung Disease-Etiology, [[Interstitial Lung Disease-Etiology]])
- Drug-Induced Pulmonary Eosinophilia (see Drug-Induced Pulmonary Eosinophilia, [[Drug-Induced Pulmonary Eosinophilia]])
Other Adverse Effects
- xxxx
References
- Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer. J Urol. 1998 Jun;159(6):2099 [MEDLINE]
- Interstitial pneumonitis related to leuprorelin acetate and flutamide. J Urol. 1999 Jan;161(1):221 [MEDLINE]
- Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer. Int J Urol. 2003 Nov;10(11):625-6 [MEDLINE]